申请人:Plettenburg Oliver
公开号:US20110190341A1
公开(公告)日:2011-08-04
The invention relates to substituted isoquinoline and isoquinolinones of the formula (I) useful for the treatment and/or prevention of diseases associated with Rho-kinase and/or Rho-kinase mediated phosphorylation of myosin light chain phosphatase, and compositions containing such compounds.
本发明涉及公式(I)的取代异喹啉和异喹啉酮,用于治疗和/或预防与Rho激酶和/或Rho激酶介导的肌球蛋白轻链磷酸酶的磷酸化相关的疾病,以及含有这些化合物的组合物。